Gene: COL12A1
Official Full Name: collagen type XII alpha 1 chainprovided by HGNC
Gene Summary: This gene encodes the alpha chain of type XII collagen, a member of the FACIT (fibril-associated collagens with interrupted triple helices) collagen family. Type XII collagen is a homotrimer found in association with type I collagen, an association that is thought to modify the interactions between collagen I fibrils and the surrounding matrix. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00467 | COL12A1 Knockout cell line (HCT 116) | Human | COL12A1 | Negative | Online Inquiry | |
KO38484 | COL12A1 Knockout cell line (HeLa) | Human | COL12A1 | 1:3~1:6 | Negative | Online Inquiry |
KO38485 | COL12A1 Knockout cell line (HEK293) | Human | COL12A1 | 1:3~1:6 | Negative | Online Inquiry |
KO38486 | COL12A1 Knockout cell line (A549) | Human | COL12A1 | 1:3~1:4 | Negative | Online Inquiry |
COL12A1 Gene Knockout Cell Lines are engineered cellular models that facilitate the exploration of the biological roles of the COL12A1 gene, known for its involvement in collagen formation and extracellular matrix structure. These knockout cell lines are created using advanced techniques like CRISPR-Cas9 that allow for precise targeting and deletion of the COL12A1 gene, resulting in a loss-of-function phenotype. This genetic manipulation permits researchers to study the effects of COL12A1 deficiency on cellular behaviors, including proliferation, differentiation, and response to extracellular signals.
The primary function of these cell lines is to provide a platform for investigating the pathophysiological contributions of COL12A1 in various diseases, particularly those linked to connective tissue disorders and fibrosis. Their mechanism of action involves disrupting normal collagen matrix assembly, enabling insights into how insufficient or abnormal collagen affects cell regulation and tissue integrity. These insights are critical, as they advance our understanding of underlying mechanisms in muscular dystrophies, cardiovascular diseases, and various fibrosis-related ailments.
In the realm of research and clinical applications, COL12A1 knockout cell lines are invaluable tools for drug development, biomarker discovery, and therapeutic strategies. Researchers utilize these models to screen potential interventions that can modulate the consequences of COL12A1 dysfunction, thus accelerating the translation of basic science into clinical treatments.
Compared to traditional models which may include wild-type cell lines or animal models, the COL12A1 knockout cell lines offer enhanced specificity and reliability, promoting reproducibility in experimental outcomes. They are tailored for high-throughput applications and can be easily integrated into existing workflows, making them an efficient choice for laboratories focused on collagen-related studies.
Researchers and clinicians will find these cell lines not only beneficial for enriching their work but also crucial for uncovering novel therapeutic avenues that address significant health issues. Our company prides itself on delivering high-quality, expertly validated biological products, and the COL12A1 Gene Knockout Cell Lines reflect our commitment to supporting scientific and medical advancement.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.